Cooley LLP has advised ImageneBio, Inc. on the deal, and Mintz has advised Leerink Partners as sole placement agent. ImageneBio, Inc. (Nasdaq: IMA) has announced the...
ImageneBio Completes $30 Million Private Placement to Advance Clinical Programs
Roche’s $1.5 Billion Acquisition of Poseida Therapeutics
Sidley Austin represented Roche in the transaction, and Cooley represented Poseida Therapeutics. Roche, one of the world’s largest biotechnology companies and the global leader in in-vitro...
Astellas’s $50 Million Investment to Support Poseida’s Commitment to Redefining Cancer Cell Therapy
Cooley LLP advised Poseida Therapeutics on the deal. Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) and Poseida Therapeutics, Inc. (NASDAQ: PSTX, CEO:...
Poseida Therapeutics’ Collaboration and License Agreement With Roche
Cooley advised Poseida Therapeutics on the deal. Poseida Therapeutics, a clinical-stage biopharmaceutical company, announced its strategic collaboration and license agreement with Roche. The agreement will leverage Poseida’s...